A Study to Assess Safety, Tolerability, Pharmacokinetics (PK), Immunogenicity, and Pharmacodynamics (PD) of Intravenous Infusions of E2814 in Healthy Participants
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Healthy Volunteers
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Other
Participation Requirements
- Age
- Between 20 years and 55 years
- Gender
- Both males and females
Description
The study will consist of 4 cohorts: in each cohort 8 participants will be randomized 3:1 to receive either E2814 or E2814-matched placebo.
The study will consist of 4 cohorts: in each cohort 8 participants will be randomized 3:1 to receive either E2814 or E2814-matched placebo.
Tracking Information
- NCT #
- NCT04231513
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon